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Activin A: An autocrine regulator of cell growth and differenti- Madin-Darby canine kidney (MDCK) cells tonically in-
ation in renal proximal tubular cells. hibited branching tubulogenesis [6]. In addition, hepato-
Background. Activin A is involved in tubular regeneration cyte growth factor (HGF) induced branching tubulogen-
after ischemia/reperfusion injury. The present study was con-
esis mainly by blocking the production of activin A [6].ducted to examine the role of activin A in cell growth, apoptosis
This raises the possibility that activin A negatively regu-and differentiation of tubular cells.
lates tubulogenesis during the kidney development [7].Methods. We performed cell proliferation assays (MTT
assay, [3H]-thymidine incorporation) and apoptosis detection Although activin A may play an important role for tubu-
assays (nuclear staining, DNA ladder formation, TUNEL stain- logenesis in kidney development, its biological effects
ing) using LLC-PK1 cells. Expression of activin and activin re- in this organ after completion of development is still
ceptor in LLC-PK1 cells also were examined by real-time poly- unknown.merase chain reaction (PCR) and immunostaining. Stable cell
Recently, we demonstrated that the expression of ac-lines expressing the truncated type II activin receptor were
tivin A was up-regulated in tubular cells after ischemia/generated and the phenotype of these cells was analyzed.
Results. Activin A inhibited DNA synthesis and cell growth in reperfusion injury [8]. Furthermore, intravenously ad-
a dose-dependent manner and induced apoptosis in LLC-PK1 ministered follistatin, which specifically binds to activins
cells. The expression level of mRNA for the activin A subunit and blocks their actions [9–11], improved renal dysfunc-
was markedly increased when the growth was stimulated. The tion and histological changes after renal ischemia [8].expression of the type II activin receptor was observed in LLC-
Follistatin also accelerated renal tubular regenerationPK1 cells. The growth rate of cells expressing dominantly neg-
by enhancing DNA synthesis and preventing apoptosisative activin receptor was significantly faster than that of
non-transfected cells. The expression level and pattern of cy- in tubular cells [8]. Based on these results, we hypothe-
tokeratin and vimentin in these cells were quite different com- sized that endogenous activin A tonically inhibits cell
pared to non-transfected cells. When cultured in collagen gel, growth, induces apoptosis and modulates differentiation
these cells formed multiple processes, which was not observed in tubular cells. To further address this issue, we exam-in non-transfected cells. Finally, the expression of Pax-2 was
ined the role of activin A in cell growth, apoptosis andmarkedly elevated in these cells.
differentiation using LLC-PK1 cells, a proximal tubularConclusions. Activin A acts as an autocrine inhibitor of cell
cell line, as a model system. The results showed that ac-growth, an inducer of apoptosis, and an important modulator
of differentiation in cultured proximal tubular cells. tivin A inhibited cell proliferation and induced apoptosis
in LLC-PK1 cells. The expression of activin and activin
receptor was observed in these cells. Furthermore, the
Activins are multifunctional cytokines belonging to blockade of activin signaling by overexpression of the
dominantly negative activin receptor promoted tubularthe transforming growth factor- (TGF-) superfamily,
cell growth and induced a phenotype resembling that ofwhich regulate cell growth and differentiation in many
progenitor-like tubular cells observed during regenera-biological systems [1, 2]. Activins are dimeric proteins
tion. We conclude that activin A acts as an autocrineand subunits of activin are expressed in various organs
inhibitor of cell growth as well as an inducer of apoptosis[3]. In the kidney, activin A is expressed in the devel-
in tubular cells, and also that it is necessary for tubularoping stage [4] and has been shown to inhibit branching
cell differentiation.morphogenesis of ureteric buds in organ culture [5]. In
an in vitro tubulogenesis model, activin A produced in
METHODS
MaterialsKey words: LLC-PK1, cell differentiation, ischemia/reperfusion injury,
apoptosis, cytokines, TGF- superfamily, tubulogenesis. Recombinant human activin A and polyclonal anti-
human activin A antibody were provided by Dr. Y. Eto 2002 by the International Society of Nephrology
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of the Central Research Laboratory, Ajinomoto Inc. DAPI stains nuclear DNA so that condensation and
division of chromatin can be readily detected.(Kawasaki, Japan). Recombinant human HGF was ob-
tained from Funakoshi (Tokyo, Japan). Epidermal
DNA electrophoresisgrowth factor (EGF) was purchased from Collaborative
Cells cultured in the serum-free medium with or with-Research (Lexington, MA, USA). Polyclonal antibody
out activin A for 48 hours were detached with trypsinagainst the activin type II receptor was generously pro-
in PBS and centrifuged together with the cells presentvided by Dr. K. Miyazono (University of Tokyo, Tokyo,
in the culture medium. The oligonucleosomal fragmen-Japan). Polyclonal anti-vimentin antibody and polyclonal
tation of DNA associated with apoptosis [13] was evalu-anti-cytokeratin antibody were obtained from Neo Mark-
ated by DNA electrophoresis using an Apoptosis Lad-ers (Fremont, CA, USA) and Dako (Glostrop, Den-
der Detection Kit (Wako Pure Chemical Industries, Ltd.,mark), respectively. Polyclonal antibody against Pax-2
Osaka, Japan) according to the manufacturer’s instruc-was obtained from Berkley Antibody Company (Rich-
tions.mond, CA, USA). Polyclonal goat anti-human Smad-2
antibody, and polyclonal rabbit anti-dipeptidyl peptidase
TdT-mediated dUTP nick end labeling staining(DPP) IV antibody were obtained from Santa Cruz Bio-
To identify nuclei with DNA strand breaks at the cell-technology, Inc. (Santa Cruz, CA, USA). [3H] Thymidine
ular level, the TdT-mediated nick end labeling (TUNEL)and [32P] deoxycytidine triphosphate were from Dupont-
method [14] was done using an Apoptosis in situ Detec-New England Nuclear (Boston, MA, USA).
tion Kit (Wako) as described previously [8]. To calcu-
late the percentage of TUNEL positive cells, we countedCell culture
all cells from four random microscopic fields at 100LLC-PK1 cells were obtained from the American Type
magnification.Culture Collection (ATCC CRL-1392; Rockville, MD,
USA) and were cultured in complete medium consisting Real-time reverse-transcription polymerase
of Medium 199 (ICN Biomedicals, Inc.) with 5% fetal chain reaction
bovine serum (FBS; Gibco BRL, Grand Island, NY,
Total RNA was extracted using TRIzol reagent (GibcoUSA), penicillin, streptomycin in an atmosphere of 5%
BRL) according to the manufacturer’s instructions. First-CO2-95% air at 37C. To obtain quiescent cells, cells strand cDNA was made from total RNA using the Super-were incubated in a serum-free medium for 48 hours.
script Preamplification System (Gibco BRL) and reverse-
transcription-polymerase chain reaction (RT-PCR) wasCulture in collagen gel
performed as described previously [8]. The expression
Cells were suspended at 5  103 cells/ml in a neutral- of Pax-2 was examined using the following primers:
ized collagen solution (Koken, Tokyo, Japan), dispensed sense and anti-sense were 5-TGCTGAATACAAACG
into 24-well plates and incubated at 37C. After the colla- ACAGAACCC-3 and 5-GCAAGTGCTTCCGCAAA
gen solution had gelled, the complete culture medium CTG-3, respectively.
was added and renewed every two to three days. The Real-time PCR was performed by the ABI Prism 7700
cultures were photographed at 5 days under phase con- Sequence Detection System using the SYBR Green PCR
trast using a Nikon Diaphot TMD inverted microscope Core Reagent Kit (Perkin Elmer Applied Biosystem,
(Tokyo, Japan). Foster City, CA, USA). Reactions included 5 L of a
10  SYBR PCR buffer, 2 L MgCl2 (50 mmol/L), 1 LMeasurement of DNA synthesis and cell viability
dNTP mix, 1 L 3 primer, 1 L 5 primer, 0.5L Ampli-
DNA synthesis was assessed by measuring [3H] thy- taq Gold and 1 L cDNA. Samples were incubated at
midine incorporation into trichloroacetic acid precipita- 94C for five minutes, followed by 40 cycles of 30 seconds
ble materials as described previously [12]. Cell viability at 94C, 30 seconds at 58C, 60 seconds at 72C, and a
was assessed by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5- final extension at 72C for 10 minutes. The expression
diphenyltetrazolium bromide] assay [6]. of the A subunit and GAPDH in each sample was quan-
tified in separate tubes with the following primers: por-
Nuclear DNA staining with DAPI cine A subunit (sense and antisense were 5-TTCGC
Cells grown on cover slips were cultured in the serum- CAACCTCA AGTCGTG-3 and 5-ATGATGTTCTG
free medium with or without 10 nmol/L activin A for CCCGTCGTCGTAG-3, respectively), porcine GAPDH
48 hours. After washing with phosphate-buffered saline (sense and antisense were 5-ATGCTGGTGCTGAG
(PBS), the cells were incubated with DAPI (4’,6-diamid- TATGTC GTGG-3 and 5-AGATGATGACCCTTTT
ino-2’-phenylindole dihydrochloride) (Boehringer Mann- GGCTCC-3, respectively). No PCR products were de-
heim, Mannheim, Germany) for 30 minutes at 37C. Cells tected in the real-time PCR procedure without reverse
transcription, indicating that the contamination of geno-were washed with PBS and mounted. The fluorescent dye
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mic DNA was negligible. Gels of the PCR products after were separated by SDS-polyacrylamide gel electropho-
resis (SDS-PAGE) under reducing condition and trans-quantification of the indicated genes by real-time PCR
showed single bands (A subunit; 83 base pair, and ferred to a polyvinylidene difluoride (PVDF) membrane
(Nihon Millipore Ltd., Yonezawa, Japan) by electroblot-GAPDH, 99 base pair, respectively) in which the size
was the same as expected (data not shown). ting. To reduce nonspecific antibody binding, the mem-
brane was blocked with 5% BSA, 0.1% NaN3 dissolved
Immunocytochemistry in Tris-saline (TS) for one hour at 37C, incubated over-
night at 4C with goat polyclonal anti-human activin typeCells cultured on cover slips were washed with PBS,
fixed with 4% paraformaldehyde, permeabilized with II receptor antibody or rabbit polyclonal anti-DPP IV
antibody, and washed with Tris-PBS (PBST). After incu-PBS containing 0.1% (vol/vol) Triton X-100 and incu-
bated sequentially with 3% bovine serum albumin (BSA) bation with peroxidase labeled anti-rabbit or anti-goat
lgG antibody for one hour at room temperature, thein PBS. Cells were then incubated with primary antibod-
ies at room temperature for one hour. After washing in membrane was washed with PBST and analyzed by expo-
sure to x-ray film using ECLWestern blotting detectionPBS, cells were covered with a mixture of a Cy3 (indocar-
bocyanine)-labeled goat anti-rabbit lgG antibody or reagent (Amersham Life Science, Tokyo, Japan).
FITC-labeled rabbit anti-mouse IgG antibody or Rhoda-
Statistical analysismine-labeled rabbit anti-goat IgG antibody and DAPI.
Immunofluorescence images were recorded with an The significance of differences between means was
compared by the Student t test, with P values of 0.05Olympus AX70 epifluorescence microscope (Olympus,
Tokyo, Japan) equipped with a PXL 1400 cooled-CCD considered significant.
camera system (Photometrics, Tucson, AR, USA), which
was operated with IP Lab Spectrum software (Signal
RESULTS
Analysis, Vienna, VA, USA).
Effects of activin A on DNA synthesis in
LLC-PK1 cellsTransfection and establishment of stable cell line
LLC-PK1 cells were transfected by Lipofectamine Plus The effects of activin A on DNA synthesis were exam-
ined in LLC-PK1 cells. Serum-starved LLC-PK1 cells wereReagent (Life Technologies, Paisley, UK) with PCXN2
plasmid containing truncated activin type II receptor incubated in complete medium containing 2% FBS with
various concentrations of activin A. As shown in Figure(tARII) and selected by continuous growth in G418
(800g/mL geneticin; Life Technologies). After five pas- 1A, recombinant human activin A induced dose-depen-
dent inhibition of FBS-induced DNA synthesis. Signifi-sages, 10 individual clones were isolated and screened
for tARII expression by Northern blot analysis. Three cant inhibitory effects of activin A on DNA synthesis
were observed at doses higher than 1 nmol/L (P  0.05).clones expressing high levels of message were identified
and routinely utilized in this study. No significant differ- No further inhibition was obtained even at a dose as high
as 20 nmol/L (data not shown). Activin A also inhibitedences were observed among these three clones in all of
our experiments. As a control, LLC-PK1 cells also were DNA synthesis induced by growth factors such as HGF
and EGF, potent mitogens for LLC-PK1 cells (data nottransfected with PCXN2 plasmid alone and grown and
maintained in G418. shown).
Effect of activin A on cell growth in LLC-PK1 cellsRNA extraction and Northern blot analysis
Total RNA (20 g) was extracted from cells using To confirm that activin A inhibits cell growth, the ef-
fect of activin A on LLC-PK1 cell growth was assessed byTRIzol Reagent. Northern blotting was done as de-
scribed previously [6]. The membrane was subjected to MTT assay. Cells were cultured for four days in complete
medium containing 2% FBS in the presence of activin Aautoradiography and analyzed using a Fujix BAS 2000
(Fuji Photo Film, Tokyo, Japan). at the indicated concentrations. Consistent with the inhibi-
tion of DNA synthesis, recombinant human activin A re-
Western blot analysis duced the cell number in a dose-dependent manner (Fig.
1B). The effect of activin A was significant (P  0.05) atCells were washed three times with PBS, suspended
in a buffer containing 50 mmol/L Tris-HCl (pH 6.8), 2% doses higher than 1 nmol/L.
sodium dodecyl sulfate (SDS), 10% glycerol, 2-mercap-
Induction of apoptosis by activin A in LLC-PK1 cellstoethanol (2-ME), and heated to 100C for 10 minutes.
After centrifugation, the supernatant was collected, and To determine whether activin A induced apoptosis in
renal tubular cells, LLC-PK1 cells were incubated withthe protein concentration was determined by using a
protein assay kit (Bio-Rad Laboratories, Munich, Ger- various concentrations of recombinant human activin A in
the serum-free medium for two days. Compared with con-many). Twenty micrograms of protein from each sample
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Fig. 1. Effect of activin A on DNA synthesis
and cell growth in LLC-PK1 cells. (A) Serum
starved cells were incubated in complete me-
dium containing 2% FBS with the indicated
concentrations of activin A. [3H] Thymidine
incorporation was measured as described in
the Methods section. Results are presented as
the mean  SE of three independent experi-
ments. (B) Cells were cultured in complete
medium containing 2% FBS with various con-
centrations of activin A for 4 days. MTT assay
was performed as described. Results are pre-
sented as the mean SE of three independent
experiments.
trol cells (without activin A), activin-treated cells showed was used to examine the expression of the type II activin
the classical morphological features of apoptosis, including receptor in LLC-PK1 cells. Figure 5 shows that the type II
chromosomal condensation (Fig. 2A) and nuclear DNA activin receptor was located within the cytoplasm of LLC-
fragmentation (Fig. 2B). These cells become TUNEL posi- PK1 cells. The reason for an apparent detection of the
tive (Figs. 2C). Quantification of TUNEL assays revealed receptor in the cytoplasm was that we did not use confocal
that activin A increased the number of apoptotic cells at microscopy. The expression level and localization of the
concentrations higher than 10 nmol/L (Fig. 2D). type II activin receptor in LLC-PK1 cells were not altered
when the growth was stimulated (data not shown). TwoInduction of cell differentiation by activin A in
bands (62 and 75 kD) were detected for the type II activinLLC-PK1 cells
receptor by Western blot analysis (Fig. 5C), which is consis-
To examine whether activin A is involved in cell differen-
tent with an earlier study [16].tiation, we studied the expression of DPP IV in LLC-PK1
cells treated with or without activin A by Western blotting.
Generation of a stable cell line expressing truncatedDPP IV is a 110 to 120 kD glycoprotein presented in
type II activin receptorthe brush border of proximal tubules and functions as a
To examine the function of endogenous activin A inhydrolase [15]. As shown in Figure 3, this apical marker
LLC-PK1 cell growth and differentiation, stable cell linesof proximal tubules was detected slightly in LLC-PK1 cells.
In contrast, the expression level of DPP IV significantly expressing the truncated type II activin receptor (LLC-
increased in LLC-PK1 cells treated with activin A. PK1-tARII) were generated that lacked the intracellular
kinase domain. Overexpression of this mutant receptor
Expression of activin A in LLC-PK1 cells blocked the activin signaling in a dominant negative fashion
Next, the mRNA expression of the A subunit of activin [17]. First, we examined the expression level of the trun-
in LLC-PK1 cells was examined by real-time PCR. As cated activin type II receptor in LLC-PK1-tARII cells by
shown in Figure 4A, the activin A subunit expression Northern blotting (Fig. 6A). Expression of its cDNA was
was very low in quiescent LLC-PK1 cells, but was strongly visible only in the lanes of quiescent LLC-PK1-tARII, butinduced when growth was stimulated with FBS. Consistent not in wild-type or vector transfected LLC-PK1 cells. Aswith the results from real-time PCR, immunoreactive ac-
shown in Figure 6B, the inhibitory effect of activin A ontivin A was observed in growing LLC-PK1 cells after growth DNA synthesis was completely abolished in LLC-PK1-tA-stimulation, which revealed granular cytoplasmic staining
RII cells. Furthermore, translocation of Smad protein intoof cells, but not in quiescent LLC-PK1 cells (Fig. 4B).
the nucleus after activin treatment was not observed in
Expression of the type II activin receptor in LLC-PK1-tARII cells (Fig. 6C), confirming the blockade
LLC-PK1 cells of activin signaling. Morphologically, there was no
change in LLC-PK1-tARII cells compared to wild-typeThe biological activity of activin is mediated by two
or vector-transfected LLC-PK1 cells in monolayer cul-different types of receptors, type I and type II [2]. Activin
first binds to the type II receptor. Immunocytochemistry ture (data not shown).
Maeshima et al: Activin A in LLC-PK1 cells450
Fig. 3. Effect of activin A on the expression of a proximal tubular cell
marker in LLC-PK1 cells. Cells were cultured in a serum free medium
with or without 10 nmol/L activin A for 48 hours. Western blot analysis
using polyclonal rabbit anti-DPP IV antibody was performed as de-
scribed in the Methods section.
significantly faster than that of either wild-type or vector-
transfected LLC-PK1 cells (Fig. 7A).
Changes in tubular cell phenotype induced by
blockade of the activin signaling
To assess the phenotype of cells expressing tARII, we
examined the expression of cytokeratin and vimentin,
which are known to be epithelial and mesenchymal cell
markers, respectively, in wild-type LLC-PK1 and LLC-
PK1-tARII cells. Indirect immunofluorescence staining
showed that the expression of cytokeratin was observed
and located in the cytoplasm in wild-type LLC-PK1 cells
(Fig. 7B, panel a). In contrast, the expression levels of
cytokeratin in LLC-PK1-tARII cells were decreased
compared to wild-type LLC-PK1 cells (Fig. 7B, panel c).
The expression level of vimentin in LLC-PK1-tARII cells
was almost similar to that of wild-type LLC-PK1 cells.Fig. 2. Effect of activin A on apoptosis in LLC-PK1 cells. (A) Cells
were cultured in a serum free medium without (panels a, b) or with However, the localization of vimentin was different. The
(panels c, d) 10 nmol/L activin A for 2 days. Staining of nuclear DNA expression of vimentin was observed surrounding the
was performed. Data are the representative of four independent experi-
nucleus and was extended from this perinuclear regionments. (b, d) Nomarski images. Magnification 400 in a-d. (B) Cells
were cultured in a serum free medium with various concentrations toward the periphery in wild-type LLC-PK1 cells (Fig.
of activin A for 2 days. DNA fragmentation was observed. Data are 7B, panel e). In contrast, vimentin distributed diffuselyrepresentative of three independent experiments. M represents the 100
throughout the cytoplasm in LLC-PK1-tARII cells (Fig.bp ladder marker. (C ) Cells were cultured in a serum free medium
without (panel a) or with (panel b) 10 nmol/L activin A for 2 days. 7B, panel g).
TUNEL staining was then done. Data are representative of three inde-
pendent experiments. Magnification is 200. (D) Quantitative analysis Changes in the morphology by blockade of the activinof TUNEL positive cells. The percentage of TUNEL positive cells was
calculated by counting all cells from four random microscopic fields at signaling in LLC-PK1 cells cultured in collagen gel
100 magnification. All stains were performed as described in the
To examine the role of endogenous activin in cell dif-Methods section. Results are presented as the mean  SE of three
independent experiments. ferentiation, a collagen gel culture system was used. Mor-
phological changes in LLC-PK1-tARII cells cultured in
collagen gel were observed for five days. When wild-
Promotion of cell growth by blockade of the type LLC-PK1 cells were cultured in collagen gel, these
activin signaling cells formed a spherical cluster (Fig. 7C, panel a). In
contrast, LLC-PK1-tARII cells cultured in collagen gelTo study the effects of the blockade of the activin sig-
formed multiple elongated processes (Fig. 7C, panel b).naling on LLC-PK1 cell growth, the growth rate of LLC-
PK1-tARII cells was examined by MTT assay. When cells
Up-regulation of Pax-2 expression by the blockade ofwere cultured with complete medium containing 0.5%
activin signalingFBS, there was no significant difference in growth rate
between LLC-PK1-tARII, wild-type and vector-trans- The expression of Pax-2 in cells expressing tARII
was examined, as Pax-2 is a transcription factor thoughtfected LLC-PK1 cells (data not shown). In contrast, when
cells were cultured with complete medium containing to be critical in organogenesis of the kidneys [18]. Pax-2,
which is expressed in embryonic kidneys, is re-expressed5% FBS, the growth rate of LLC-PK1-tARII cells was
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Fig. 5. Expression of the type II activin receptor in LLC-PK1 cells.
Serum-starved cells were cultured in complete medium containing 5%
FBS for 2 days. Immunocytochemistry was performed as described in
the Methods section (magnification 400). (A) Type II activin receptor
(red) and nuclei (blue). (B) Nomarski image. (C ) Immunoblot analysis
using anti-human type II activin receptor.
to restore the functional integrity of the nephron [20].
Several growth factors have been reported to be poten-
tially involved in kidney regeneration and play important
roles in these processes as a mitogen, motogen, and mor-Fig. 4. Expression of activin A in LLC-PK1 cells. (A) Time course of
A subunit mRNA expression in LLC-PK1 cells after growth stimulation. phogen [21–25].
Serum starved cells were cultured in complete medium containing 5% The present study demonstrated the expression of ac-FBS. Total RNA was extracted at indicated times. Real-time RT-PCR
tivin A and the activin receptor in LLC-PK1 cells. In ad-was performed as described in the Methods section. Results are pre-
sented as the mean SE of three independent experiments. (B) Repre- dition, the expression of activin A in LLC-PK1 cells was
sentative data of immunoreactive activin A in LLC-PK1 cells. Serum not detected in a quiescent state, but was markedly up-starved cells (panels a, b) were cultured in complete medium containing
regulated when growth was stimulated. We previously5% FBS for 2 days (panels c, d). Immunocytochemistry was performed
as described in the Methods section (magnification400; a and c, activin showed that activin A is up-regulated in tubular cells af-
A (red), nuclei (blue); b and d, Nomarski image). ter renal ischemia [8], whereas the expression of the ac-
tivin receptor was ubiquitously observed in tubular cells
of the kidney [8]. Collectively, activin A acts as an auto-
crine factor in tubular cells both in vivo and in vitro. LLC-
PK1 is a renal epithelial cell line derived from proximal
in tubular cells of the regenerating kidney in adults [19]. tubular cells [26], which actively participates in cell growth
As shown in Figure 8A, the expression of Pax-2 was during tubular regeneration [20]. These cells provide a
markedly increased in LLC-PK1-tARII cells, but not in useful model to study the activin action on tubular cells
either the wild-type or mock-transfected cells. Likewise, in detail.
immunoreactive Pax-2 was detected in the nuclei of LLC- The present results show that activin A inhibited cell
PK1-tARII but not in wild-type LLC-PK1 cells (Fig. 8B). growth in a dose-dependent manner and induced apo-
ptosis in LLC-PK1 cells; furthermore, the blockade of the
activin signaling by overexpressing the truncated type II
DISCUSSION activin receptor promoted cell growth. The growth rate
Adult tubular epithelium has a potential of regenera- of LLC-PK1-tARII cells was faster than that of wild-
tion following a variety of insults. During tubular regen- type or vector-transfected cells. Collectively, activin A
eration, quiescent cells undergo dedifferentiation, re- functions as an autocrine inhibitor of cell growth in LLC-
PK1 cells. The expression of activin A was induced inobtain their potential to divide, and then differentiate
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Fig. 6. Generation of LLC-PK1 cells express-
ing truncated type II activin receptor. (A) Ex-
pression of truncated type II activin receptor
mRNA in LLC-PK1 cells. Cells were trans-
fected with PCXN2 plasmid containing trun-
cated type II activin receptor cDNA and sta-
ble transfectants were selected by neomycin
resistance. Hybridization with a cDNA probe
of tARII was detectable only in the tARII-
transfected LLC-PK1 cells (lane 3), but not in
wild-type (lane 1) or vector-transfected cells
(lane 2). (B) Effect of activin A on DNA syn-
thesis in wild type and tARII-transfected
LLC-PK1 cells. Serum-starved wild type ()
and transfected () cells were incubated in
complete medium containing 2% FBS with
the indicated concentration of activin A. [3H]
Thymidine incorporation was measured as de-
scribed in the Methods section. Results are
presented as the mean SE of three indepen-
dent experiments. (C ) Localization of Smad-2
protein in vector-transfected (panel a) and
tARII-transfected (panel b) LLC-PK1 cells.
Cells were cultured in a serum-free medium
containing 10 nmol/L activin A for 30 minutes.
Then the cells were washed with PBS and
fixed with 4% paraformaldehyde. Immunocy-
tochemistry was performed as described (mag-
nification 1000).
LLC-PK1 cells, regardless of growth stimuli, suggesting the growth is stimulated by complete medium containing
5% FBS. We also observed an increase in the expressionthat these cells are programmed to express activin A
when the growth was stimulated. If this idea could be level of activin A when the growth is stimulated by HGF
or EGF (data not shown). These factors are local reg-applied to the regeneration processes of the kidney, it
is possible that, during regeneration after renal ischemia, ulators of tubular cell growth after renal injury [23–26].
Hence, these mitogens may induce the expression of ac-proliferating tubular cells are programmed to express
activin A and then stop cell growth or lapse into apopto- tivin A during regeneration. Pro-inflammatory cytokines
also are possible mediators of activin expression. It wassis for the prevention of excessive cell growth. On the
other hand, activin A enhanced the expression level of reported that the expression level of activin A was corre-
lated with the degree of inflammation in inflammatoryDPP IV, an apical marker of proximal tubules. This ob-
servation suggests that activin A has the potential to bowel disease [28, 29]. A strong expression of activin A
was induced by the pro-inflammatory cytokines such asinduce, at least in part, maturation of proximal tubular
cells. Therefore, it is likely that activin A is a growth interleukin-1 (IL-1) and tumor necrosis factor- (TNF-)
in vitro [30]. In an ischemia/reperfusion model, reperfu-inhibitor as well as a regulator of cell differentiation to
restore epithelial integrity of the tubules during regen- sion induces inflammation such as neutrophil infiltration
in the kidney, potentially contributing to the develop-eration.
It should be noted that renal regeneration after renal ment of postischemic tubular cell death [27]. Neverthe-
less, no induction of activin expression was observed inischemia is a complex phenomenon regulated by variety
of factors. Hence, the present study does not address LLC-PK1 cells treated with pro-inflammatory cytokines
such as TNF- or IL-6 (unpublished observation). Thus,all of the mechanisms involved in vivo. For example,
neutrophils are activated after renal ischemia and resul- pro-inflammatory cytokines may not induce activin ex-
pression during regeneration of the kidney.tant release of bioactive substances induce tubular dam-
age [20, 27]. Those aspects were not mentioned in the Progenitor-like tubular cells with high proliferative po-
tential participate in tubular regeneration [21, 22]. Thesepresent study.
The up-regulation of activin expression is significant cells express a mesenchymal marker, vimentin, and re-
semble immature mesenchymal cells observed duringin the regeneration processes of the kidney [8]. We then
asked which mechanism regulates the expression of ac- kidney development [31]. In the present study, we ob-
served that the expression level of cytokeratin, an epithe-tivin in tubular cells. Possibly the most important media-
tor of activin A expression is the mitogens for tubular lial marker, was decreased in LLC-PK1-tARII cells com-
pared to wild-type LLC-PK1 cells. The expression levelcells. Our present study shows that the expression of ac-
tivin A was markedly increased in LLC-PK1 cells when of vimentin was almost similar to that of wild-type LLC-
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Fig. 8. Expression of Pax-2 in LLC-PK1 cells expressing truncated
type II activin receptor. (A) Expression of Pax-2 mRNA in wild-type
(lane 1), vector-transfected (lane 2), and LLC-PK1-tARII (lane 3) cells
was examined by RT-PCR. Data are representative of three indepen-
dent experiments. (B) Localization of Pax-2 protein in wild-type (panels
Fig. 7. Characteristics of LLC-PK1 cells expressing truncated type II a, b), and LLC-PK1-tARII (panels c, d) cells was examined by indirect
activin receptor. (A) Growth rate of LLC-PK1 cells expressing truncated fluorescence immunostaining. Note that Pax-2 protein (red) was local-
type II activin receptor wild-type (), vector-transfected () and ized in the nuclei (blue) of LLC-PK1-tARII cells, but was not observed
tARII-transfected () LLC-PK1 cells were cultured in complete me- in wild-type LLC-PK1 cells. b, d: Nomarski images. Magnification400.
dium containing 5% FBS for indicated periods. MTT assay was per-
formed as described in the Methods section. Results are presented as
the mean  SE of three independent experiments. *P  0.01 vs. wild-
type. (B) Expression and localization of cytokeratin and vimentin in
LLC-PK1 cells expressing truncated type II activin receptor wild-type differentiated properties and maturation of tubular cells
(panels a, b and e, f) and LLC-PK1-tARII (panels c, d and g, h) cells in the regeneration processes of the kidney.
were cultured on cover slips, washed with PBS and fixed with 4%
In summary, our results show that activin A tonicallyparaformaldehyde. Localization of cytokeratin (a-d) and vimentin (e-h)
was determined by immunocytochemistry as described in the Methods inhibited cell growth, induced apoptosis and was needed
section. (b, d, f, h) Nomarski images, magnification 1000 in a-d and for maintaining differentiation functions in LLC-PK1 cells.
400 in e-h. (C ) Morphological changes in LLC-PK1 cells expressing Activin A is likely to be up-regulated in tubular cells totruncated type II activin receptor cultured in collagen gel. Wild-type
(panel a) and LLC-PK1-tARII (panel b) cells were cultured in collagen prevent abnormal cell growth and to induce differentia-
gel for 5 days as described in the Methods section (magnification400). tion and maturation during tubular regeneration.
Note that multiple processes (arrowheads) were observed in LLC-PK1-
tARII cells, but not in wild-type cells.
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